Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

How Stephanie C. Raised $500,000 for the 3-Day  

For years, Stephanie C. has lived by a simple motto: “If you can, you should.” 

Since joining the Susan G. Komen 3-Day® in 2006, she has worked tirelessly to put those words into action year after year. Through her dedication, passion and the support of her community, Stephanie recently surpassed an incredible milestone: raising more than $500,000 to support the fight to end breast cancer.

Why I Became a Komen College Ambassador

One student. One mission. A conversation about breast health, community and showing up for the people you love.  Yaleska is a junior studying biological sciences and global health at Northwestern University in Evanston, Ill. When she heard about the Komen College Ambassador Program, she didn’t hesitate in signing up. This Women’s Health Month, we sat down with her to talk about what brought her here, what she’s learned and what she wants every young woman on her campus to know; read below, in her own words. Why did you sign up to become a Komen College Ambassador?   After being scheduled for a mammogram, I realized that having breast cancer was possible at my young age. I wanted to make a difference in my campus by educating both men […]

Four smiling women stand together outdoors at a golf breast cancer fundraiser, wearing matching gray shirts with pink floral designs and “I’m Still Standing – Breast Cancer Awareness” printed on them.

Friends, Fairways and a Mission to End Breast Cancer

At Deep Creek Golf Club in Punta Gorda, Fla., what began as a small women’s league event has grown into a beloved golf breast cancer fundraiser. The club’s annual Rally for the Cure event – organized through Komen’s Go Pink for the Cure sports fundraising program – brings the local golfing community together to raise funds to support Komen and the fight to end breast cancer.

Medicine,Development,Laboratory:,Asian,Female,Scientist,Using,Microscope,,Analyzes,Petri

Komen-Funded Researchers Are Pioneering Lifesaving Advancements in Early and Metastatic Triple Negative Breast Cancer 

Triple negative breast cancer (TNBC) is an aggressive breast cancer that’s challenging to treat. Making up about 15-20% of all breast cancers, TNBC lacks three common tumor characteristics (biomarkers) that breast cancer treatments usually target: the estrogen receptor (ER), progesterone receptor (PR) and HER2 protein. Without these biomarkers, the cancer tests negative for all three, meaning it cannot be treated with standard hormonal therapies or HER2-targeted medications.   Because TNBC tumors tend to recur (come back) within the first five years and with limited treatment options, it’s a high […]

Women’s Health Month: The ShareForCures® Alliance and Living Beyond Breast Cancer (LBBC) 

Where Community and Personalized Resources Meet   During Women’s Health Month, conversations about breast cancer often focus on screenings, treatment and survival rates. But life with and beyond breast cancer is about more than medical appointments. It is also about mental health, community and feeling seen through every stage of the experience. That’s where Living Beyond Breast Cancer, also known as LBBC, comes together with […]

Komen Has Helped Pave the Way for 31 FDA-Approved Breast Cancer Drugs Over the Past 30 Years

Over the past 30 years, 31 FDA-approved breast cancer drugs have a connection to Komen. “We are able to show the points along the research pathway for each of the 31 drugs where Komen funding has helped in development and eventual clinical use, either through investments in direct studies or investments in people doing the research,” she said.

Breast Cancer Breakthroughs Episode 21: Real World Impact of Oral SERDs 

Real-world evidence involves gathering information about how a drug performs in routine clinical practice, outside of clinical trials. Knowing the real-world impact of a drug can help patients and their doctors make more informed decisions about their treatment.  In this episode of Breast Cancer Breakthroughs, we speak with Komen Scholar Donald McDonnell; Ph.D., medical oncologist Maryam Lustberg, M.D., M.P.H.; and METAvivor President Kelly Shanahan, M.D., as they talk about the real-world evidence and clinical use of oral selective estrogen receptor degraders (SERDs), how these drugs have […]

A Komen Guide to the 2026 American Society of Clinical Oncology Annual Meeting (ASCO)  

This is a guide to ASCO 2026 with Susan G. Komen. Each year, thousands of cancer researchers, doctors, advocates and health care professionals amass at the American Society of Clinical Oncology Annual Meeting, commonly known as ASCO. This year’s meeting starts on May 29 and lasts five days in Chicago (with a virtual option as well). Last year’s meeting had nearly 45,000 people registered, making it one of the largest cancer research meetings […]

Post-Surgical Recovery for Breast Cancer: Expectations, Challenges and More 

Post-surgical recovery for breast cancer expectations, challenges and advances in care are important to consider whether you are having a lumpectomy, mastectomy, reconstruction or other breast surgery. By learning what to expect, what happens during the healing process and your recovery options, you can feel more confident in the process.     Preparing your home and loved ones  “The best way to get a good outcome after surgery is to be prepared before the […]